ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 744450 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 744450; 2) Community: the network communities that were significantly associated with the response to NSC 744450; 3) Molecule: the relationships between components within communities and NSC 744450; 4) MDR: the compounds that were significantly associated with the NSC 744450.

NSC Compound Enrichment Correlation
NSC 275647 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-8-(methoxyacetyl)-, hydrochloride, (8S-cis)- 0.0105244982742819 -0.076928382
NSC 313681 Oxiperomide(USAN) 0.0105244982742819 -0.0041285116
NSC 351521 Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) 0.0105244982742819 -0.14225355
NSC 603071 Aminocamptothecin 0.0105244982742819 -0.039669758
NSC 603578 Platinum, tetrachloro[dimethylsilylenebis(methanamine)]-, (OC-6-22) 0.0105244982742819 -0.036118287
NSC 606497 Camptothecin Derivative 0.0105244982742819 -0.033087241
NSC 673652 2-Ethylaminoestradiol 0.0105244982742819 -0.16516427
NSC 673787 Null 0.0105244982742819 -0.19551879
NSC 683556 Camptothecin Derivative 0.0105244982742819 0.0040926205
NSC 683833 Null 0.0105244982742819 -0.26051317
Total:65  Current:14    [First] [Prev] [Next] [Last]